Increased glutamate in CSF and plasma of patients with HIV dementia.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsExpression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia?HIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsMitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infectionNeuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.A glutamate-dependent redox system in blood cells is integral for phagocytosis in Drosophila melanogaster.Glutamate, T cells and multiple sclerosis.Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsCerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.HIV-1 Tat inhibits EAAT-2 through AEG-1 upregulation in models of HIV-associated neurocognitive disorder.Glutamate metabolism and HIV-associated neurocognitive disorders.Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorderHeme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disordersNeurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome.Glutamatergic systems in Alzheimer's disease.Brain to blood glutamate scavenging as a novel therapeutic modality: a reviewMolecular mechanism of HIV-1 Tat interacting with human dopamine transporter.Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase.Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminaseNeuroprotective strategies for HIV-1 associated dementia.Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral TherapyGlutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders.Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.Blood glutamate scavenging: insight into neuroprotection.Glutaminase-containing microvesicles from HIV-1-infected macrophages and immune-activated microglia induce neurotoxicity.Extracorporeal methods of blood glutamate scavenging: a novel therapeutic modality.Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment.Neuropathologic contributions to understanding AIDS and the central nervous system.Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disordersMetabolic markers of neuronal injury correlate with SIV CNS disease severity and inoculum in the macaque model of neuroAIDSCombined and independent effects of chronic marijuana use and HIV on brain metabolites.Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter.
P2860
Q26766448-2B5CE609-F73C-435D-B9DA-E7ADCFEF1384Q28075692-117D84DE-F30A-49F9-841C-7D1754AB4EEBQ28206867-9FF65B2A-3FCB-46B1-9977-53C38118C3BAQ28392199-E0637B68-CBA8-483A-848F-5AC9DE5F5EBDQ28396045-3F10326B-7851-4B0F-B40A-74520DEB3F29Q30569766-4983F555-FECF-4CF4-A9D8-DF1BD09F4CC3Q30577533-8AC1BA07-E357-4647-8A88-5ADBE5C610A5Q31165986-ED8369CF-AD0E-4A9E-AE1D-1CC3B1BF7F0BQ33247010-7D05247F-22F7-49A3-AE10-DBC5B886C417Q33614467-2AEB8A45-06E0-49D1-92BB-EB71D7B34CFEQ33863368-1D802159-3C74-488D-8801-533136F1A72AQ33889434-162737F0-D765-4ED5-98E0-6F0FA84D8518Q33903612-0CF647B2-BBB5-4B61-97D8-FB89F3964A7CQ34018675-2F392CCB-E376-40E5-A7BE-CC351ABA0420Q34037622-066028DA-8026-4D81-9987-16750D055A60Q34139883-BB78C196-54CD-495D-8A47-23DB37C86292Q34238406-C3039966-82FF-45BE-8D1E-FC9D2D5D8B31Q34257820-2602D7FD-F807-4F33-A432-DA564546919BQ34311736-A1095EEB-8472-4FA2-AC4B-1D4B8BDC9F02Q35065220-5661392E-35BE-4BB1-8CF8-62BF1BBFAD6DQ35218753-EF8251D7-C6A9-41FA-B0A5-3FAA801124B3Q35241461-6014C368-1957-4314-9FDF-28C449842227Q35450098-BF23D649-65B3-4D89-B728-AA6A420084CFQ35699016-7F1181AC-224D-4F23-A24C-D5E4A25D0045Q35990460-A2EDDC6E-C329-4629-9D20-2620F8EF2363Q36003825-FA01A177-A48F-4708-A5B9-6E30E66B3225Q36074026-E014AD16-864B-41C3-A230-C5E0E458B653Q36086223-2C5A078C-B507-438D-A9EF-92605393E61DQ36124818-601865CC-6799-49E0-9422-C92E34CB06B7Q36164951-E6E7BF55-0519-4165-B407-916B3475E5CAQ36202424-E8F80F7A-DA0A-4565-A0AD-83924BE89042Q36256681-EE71DDC0-2A80-4805-918E-34BCE735A703Q36338394-D5D3067F-E2A9-41DE-8004-6A7383544A19Q36655069-E3E16192-1BCD-4120-A7EA-402A98E5F461Q36771870-C3DE93C6-2287-4E55-8ACB-1C4F8A70E2C1Q36844731-DC43B60D-E886-425D-8CAA-0A1D160ED49EQ36868552-56101EAD-72DB-42B6-B462-B3F643CC4F72Q36920071-9201EC6E-A17D-4DDE-B4E8-E9DDF48C7912Q36983868-BAC0FEFF-FB18-4FBA-9241-4569CAC8F747Q37035634-3FEF7FB5-45E2-4EF0-85F4-74F9B47E49F2
P2860
Increased glutamate in CSF and plasma of patients with HIV dementia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Increased glutamate in CSF and plasma of patients with HIV dementia.
@en
type
label
Increased glutamate in CSF and plasma of patients with HIV dementia.
@en
prefLabel
Increased glutamate in CSF and plasma of patients with HIV dementia.
@en
P2093
P356
P1433
P1476
Increased glutamate in CSF and plasma of patients with HIV dementia.
@en
P2093
Aliprandi A
De Micheli A
Ferrarese C
Frattola L
Stanzani L
Tremolizzo L
P304
P356
10.1212/WNL.57.4.671
P407
P577
2001-08-01T00:00:00Z